key: cord-0994979-82ef3b30
authors: Saud, Z.; Tyrrell, V. J.; Zaragkoulias, A.; Protty, M. B.; Statkute, E.; Rubina, A.; Bentley, K.; White, D. A.; Dos Santos Rodrigues, P.; Murphy, R. C.; Kofeler, H.; Griffiths, W. J.; Alvarez-Jarreta, J.; Brown, R. W.; Newcombe, R. G.; Heyman, J.; Pritchard, M.; Mcleod, R. W.; Arya, A.; Lynch, C.-A.; Owens, D.; Jenkins, V.; Buurma, N. J.; O'Donnell, V. B.; Thomas, D. W.; Stanton, R. J.
title: The SARS-CoV2 envelope is distinct from host membranes, exposes pro-coagulant lipids, and can be inactivated in vivo by surfactant-containing oral rinses.
date: 2022-02-17
journal: nan
DOI: 10.1101/2022.02.16.22270842
sha: b1806239e6eb2c67f6acb842b9af76d00310bfd0
doc_id: 994979
cord_uid: 82ef3b30
The lipid envelope of SARS-CoV2 is an essential component of the virus, however its molecular composition is unknown. Addressing this knowledge gap could support the design of anti-viral agents, and further understanding of viral interaction with extracellular host proteins, infectivity, pathogenicity, and innate immune system clearance. Lipidomics analysis of SARS-CoV2 particles generated from Vero or A549 cells revealed that the virus envelope comprised mainly of phospholipids (PL), primarily phosphatidylcholine (PC), phosphatidylethanolamine (PE) and phosphatidylinositol (PI), with very little cholesterol, sphingolipids or other lipids, indicating significant differences from host membranes. Unlike healthy cellular membranes, procoagulant aminoPL (aPL), specifically PE and phosphatidylserine (PS), were present on the external side at levels far exceeding those seen on activated platelets. As a result, purified virions directly promoted coagulation. To investigate whether these differences enabled the viral envelope to be selectively targeted at relevant sites in vivo, we tested whether non-toxic oral rinses containing lipid disrupting chemicals could reduce viral infectivity. Products containing PL-disrupting surfactant solutions (cetylpyridinium chloride (CPC) or ethyl lauroyl arginate) met EN14476 virucidal standards in vitro, however products containing essential oils, PVP-I, or Chlorhexidine did not, nor did rinses containing components that altered the critical micelle concentration of CPC. This result was recapitulated in vivo, where a 30-second oral rinse with CPC-mouthwash eliminated live virus in the oral cavity of COVID19 patients for at least 1hr, while PVP-Iodine and saline mouthwashes were ineffective. Thus, the SARS-CoV2 lipid envelope is distinct from the host plasma membrane which may enable design of selective anti-viral approaches, it exposes PE and PS which may influence thrombosis, pathogenicity, and inflammation, and can be selectively targeted in vivo by specific oral rinses.
The SARS-CoV2 envelope from Vero or A549 cells is phospholipid (PL) rich and varies depending on 119 cellular origin. 120 SARS-CoV2 England 2 strain was grown in VeroE6 or A549 monolayers and purified using density 121 gradient centrifugation. A549 stably expressed ACE2 and TMPRSS2 to enhance infectivity (35). Purity 122 of virus was confirmed by Nanoparticle tracking analysis, with a single peak observed at approximately 123 100nm (Figure 1 A) , and by western blot demonstrating absence of actin as a cellular marker from the 124 purified virus (Figure 1 B, Supplementary Figure 1 A,B) . The absence of serum lipid contamination in 125 purified virus was confirmed using precursor scanning for PE, PC and CE (data not shown). and TAGs were also seen (Figure 1 C insets) . 146
The SARS-CoV2 membrane contains low amounts of cholesterol, SM and PS, relative to other PL. 147
Next, mol% was calculated for PL and sphingolipids only, since this allows comparison with older 148 studies on composition of intracellular membranes of mammalian cells, which used thin layer 149 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.22270842 doi: medRxiv preprint loss of infectivity (Figure 4 D) . When mouthwashes (without virus) underwent SEC, the flow-through 248 was non-toxic against the cell monolayer for all products with the exception of SCD Ultra (Figure 4 C) . 249 SEC was therefore used for all in vitro mouthwash testing. These optimisations enabled the detection 250 of a >5-log10 decrease in virus titre, with the exception of SCD Ultra for which a >4-log10 decrease 251 was measurable. This is above the 4-log10 reduction in activity specified by EN14476, allowing the 252 testing of mouthwash to international virucidal standards, as detailed below. 253
Next, the ability of mouthwash to reduce virus infectivity, after a 30-second exposure in a soil load, 254 was tested using the optimised plaque assay. Two CPC-containing mouthwashes (Dentyl Dual Action, 255
Dentyl Fresh Protect) and a mouthwash containing 23% v/v ethanol/LAE (Listerine® Advanced DGT) 256 eradicated the virus completely, giving >5-log10 reduction in viral titres, and thus met EN14476 as a 257 virucide. In contrast, only moderate effects (~3-log fold reduction) were observed with PVP-I (Videne), 258 CPC/sodium citric acid/benzoate (SCD Ultra) and 21 % v/v alcohol/essential oils (Listerine® Cool Mint) 259 (Figure 4 E), which failed to meet EN14476. Chlorhexidine (Corsodyl; <2 log fold reduction) was least 260 effective. 261
For products with antiviral activity, it is relevant to determine selectivity for the virus as opposed to 263 host cells, since potential toxicity in vivo should be considered. We showed that the SARS-CoV2 264 membrane is similar to ER/Golgi in terms of PL composition (Table 1) , and unlike plasma membrane is 265 extremely low in cholesterol and SM. However, whether this is sufficient to reveal differential impacts 266 of oral rinses needed to be experimentally determined. We compared the sensitivity of To determine which components were responsible for this activity, SARS-CoV2 was exposed to active 280 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.22270842 doi: medRxiv preprint constituents (alone or combined) from the relevant rinses, using concentrations found in individual 281 formulations (Figure 5 B, Table 2 ). CPC, the active component in Dentyl Fresh Protect, eradicated live 282 virus at both concentrations tested (Figure 5 B) . Dentyl Dual Action contains CPC/isopropyl myristate 283 (IPM) in a biphasic aqueous-oil system that requires shaking before use. CPC is predominantly in the 284 aqueous phase, while IPM is predominantly in the oil layer. The fully-shaken rinse completely 285 eradicated live virus (Figure 5 B) . The aqueous CPC layer (without prior mixing) was also effective, as 286 was the aqueous layer obtained after shaking followed by 2 min settling (to ensure IPM saturation of 287 the CPC layer) (Figure 5 B) . Thus, CPC alone can eradicate SARS-CoV2 and IPM isn't required. 288
Listerine®Advanced DGT contains ethanol at 23 % v/v and LAE (3.3 mM), while other formulations 289 (e.g. Listerine®Cool Mint) contain ethanol with essential oils: thymol, menthol and eucalyptol. Whilst 290 23 % v/v ethanol alone had no consistent impact, the addition of thymol (5 mM) resulted in a 3-log 291 reduction in virus titres (Figure 5 B ). This indicates that Listerine®Cool Mint reduces virus titres due to 292 the essential oils, with ethanol mainly providing oil solubility. Aqueous solutions of LAE below (3.3 293 mM) and above (9.9 mM) the critical micelle concentration (cmc, 4.9 mM (43)), completely eradicated 294 SARS-CoV2, mirroring the potent anti-viral activity of Listerine® Advanced DGT, which contains 3.3 295 mM LAE (Figure 5 B) . This was seen with or without 23 % ethanol inclusion, indicating that LAE is 296 responsible for the antiviral activity of this product. To determine the potential effect of charge on 297 molecular interactions with the viral lipid membrane, in addition to CPC and LAE (cationic surfactants), 298 the effect of the anionic surfactant dodecylbenzensulfonate (DBS) was tested and found to completely 299 eradicate infectivity (Figure 5 B) . 300
One mouthwash (SCD Ultra) showed only a 3-log reduction in virus titres despite containing CPC 301 (Figure 4 E). This formulation also contains citrate and benzoate. When these were separately added 302 to CPC, citrate had no effect, however benzoate reduced the ability of CPC to kill virus (Figure 5 C). 303 Therefore, while surfactants such as CPC are essential for antiviral activity, additional components 304 may dampen effectiveness in inactivating SARS-CoV2. 305 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.22270842 doi: medRxiv preprint enough to be admitted to hospital, many were likely beyond this timepoint. Unfortunately, this was 314 not known at the time sample collection was initiated and only became evident towards the end, with 315 the study terminated at 6 months. By then, new UK daily cases had decreased from 55,892 (31 st Dec 316 2020) to 4,052 (31 st March 2021), hospitalised patient numbers were declining and co-morbidity and 317 ventilatory support in these patients rendered them ineligible for randomisation 318 (https://coronavirus.data.gov.uk), making further recruitment impossible. Amongst patients with 319 live virus, saliva was collected before rinsing (baseline), and at 1-, 15-, 30-, and 60-minutes post-320 rinsing, with mouthwashes containing either containing CPC/IPM (Dentyl Dual Action, n = 8), 321 CPC/benzoate (SCD Ultra, n = 7), PVP-I (Videne, n = 6) or 0.9% w/v NaCl (Normasol, n = 6). Data is 322
shown as both log2-fold reduction from baseline (Figure 5 D) and as individual patient data ( Figure 6) . 323
Across the entire cohort, baseline salivary viral load varied widely, from 120 PFU/ml to 2.8 x 10 7 324 PFU/mL (Supplementary Data1.xls). All four mouthwashes reduced salivary viral load 1-minute post-325 rinsing, with the smallest reduction being from Normasol® (median 3.9 log2 fold reduction from 326 baseline) and the largest Dentyl Dual Action where 6/7 patients recorded no live virus (median 14.3 327 log2 reduction from baseline) (Figure 5 D, Tables 3,4 ). The persistence of the effects varied with rinse. 328
No significant reduction in salivary viral load was seen with Videne at any of the time-points, while for 329 Normasol® a significant reduction was apparent only at 60 minutes. For SCD Ultra, a significant 330 reduction in viral load was seen at 1 minute only (median 8.9 log2 reduction from baseline, Figure 5 331 D). Dentyl Dual Action was the only product to demonstrate a persistent effect, with a significant 332 reduction evident throughout at 1, 15, 30 and 60 minutes respectively (medians 14.3, 11, 8.8, 9, log2 333 reduction from baseline). Impressively, in 3/8 patients treated with Dentyl Dual Action, no live virus 334 was recovered at any timepoint after the initial rinse ( Figure 6 ). 335 336 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Here, we found that the SARS-CoV2 membrane is primarily comprised of PC, PE and PI, while having 350 low levels of free cholesterol, PS and SM. This appears most similar to ER, although with even lower 351 proportion of PS, SM and cholesterol than previously reported for that membrane compartment, 352 using older methods. In the mammalian plasma membrane, cholesterol is often concentrated in 353 specialised regions which support receptor dependent signalling, called lipid rafts(46). Our data 354 suggest these will be absent from the viral envelope. Furthermore, the cholesterol in plasma 355 membranes regulates fluidity and reduces permeability to small molecules, while SM is also important 356 for reducing fluidity(47-49). Thus, the viral envelope and plasma membrane will be very different 357 biophysically. Similarly, bacterial membranes are also considered to be devoid of cholesterol. In this 358 context, this is exploited therapeutically since cholesterol protects host cells from disruption by anti-359 microbial peptides which directly insert in the bacterial membrane (50 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.22270842 doi: medRxiv preprint noted, with little PUFA evident. This most likely reflects the typical FA composition of cultured cells 370 which tend to be lower in PUFA than primary tissues. In human disease, the SARS-CoV2 virus will be 371 actively replicating in oral, nasal and airway epithelia. Studies on airway and tracheal cells have shown 372 their FA composition to be similar to what was seen here, but with significantly more 18:2 and 20:4, 373 which becomes lowered during cell culture (52, 53). Thus, virus generated in human airways in vivo 374 may have more PUFA than found herein, but this remains to be determined. Notably, we found 375 significant differences in SARS-CoV2 virus lipids, depending on the host cell in which they were 376 generated. This may relate to subtle differences in host cell ER membranes between the cell types. 377
Importantly, inflammation has a significant impact on host cell lipid metabolism, and how this 378 influences virion envelope composition now needs to be tested. 379
Here, we showed that SARS-CoV2 exposes around 50% of its total molecular species of aPL on the 380 surface of the particle ( Figure 4B ). As a caveat of the method, membrane proteins or sugars could in 381 theory hinder derivatisation of aPL, and so this value may be a lower-level estimate. In primary cells, 382 energy-dependent processes maintain asymmetry of plasma membranes. This ensures that very low 383 mol% of PE and PS are exposed on the surface, for example, only 3 -4 % is present on platelets 384 following thrombin activation (40). This is because PE and PS promote coagulation, complement 385 binding and uptake of apoptotic cells through their electronegative interactions with Ca 2+ ions and 386 various proteins (3, 20, 40). Although the overall amounts of PS appear to be rather low in virions, PE 387 levels are similar to plasma membrane (Table 1) . Thus, exposure of 50 % of aPL on the surface will 388 result in levels of external PE that are around 12-fold-higher than activated platelets(40). Indeed, in 389 line with this, we found that purified virions significantly accelerate plasma coagulation in vitro ( Figure 390 4 B). In addition, a recent study showed (using a less specific ELISA) that levels of PS on the surface of 391 SARS-CoV2 are sufficient to support PS-receptor dependent viral entry (17). Our work extends this 392 significantly by reporting on the ng amounts of PS and PE present, the proportions of PE and PS that 393 are externalised, and the specific molecular species of PE and PS in the membrane. In addition to SARS-394
CoV2, PS has been implicated in the cellular uptake of several other viruses, thus knowing how much 395 and which molecular species are external facing on the envelope is relevant to other infectious 396 diseases (10-16). In summary, our study and others suggest that targeting aPL could support anti-397 thrombotic, anti-inflammatory or anti-viral strategies for COVID19. 398
These findings could also be relevant for other enveloped respiratory viruses such as influenza which 399 has long been considered to trigger thrombotic complications of atherosclerosis, including myocardial 400 infarction. Winter peaks in influenza are often followed two weeks later by a peak in ischemic heart 401 disease, hypertension and cerebrovascular disease deaths. Furthermore, many acute vascular events 402 follow upper respiratory infections (reviewed in detail in (54)). A recent study found that emergency 403 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.22270842 doi: medRxiv preprint department visits for respiratory illness were both associated with, and predictive of, cardiovascular 404 disease mortality in adults >65 yrs (55). Furthermore, in a meta-analysis, influenza vaccination was 405 associated with lower risk of adverse cardiovascular events (56). The mechanisms are unknown and 406 a vascular inflammatory component is likely to play a role. Thus, other enveloped viruses are also 407 strongly associated with thrombotic events, however whether virions themselves directly contribute 408 to coagulation has never been evaluated. 409
Having determined the composition of the lipid membrane, we next tested the impact of common 410 mouthwash formulations, focusing on surfactants which we reasoned would effectively target a PL-411 rich membrane. Our data significantly extends other recent studies on enveloped viruses. has achieved 4-log10 kill required to pass EN14476 as a virucidal, although this was tested against 418
HCoV229E rather than SARS-CoV2(30). Here, we employed live SARS-CoV2 England2 strain, and 419 demonstrated that several mouthwashes (Listerine®Advanced DGT, Dentyl Fresh Protect, Dentyl Dual 420 Action) pass EN14476 against this virus. 421 Importantly, efficacy was not dependent on 'classical' antibacterial components of mouthwashes, but 422 instead was critically dependent on the presence of surfactant (CPC/LAE). Whether any of the lipid 423 disrupting components would function in this way was not predictable from the outset; efficacy is 424 determined by both molecular makeup and concentration, with some detergents (e.g. Tween20) not 425 inactivating SARS-CoV2 even at 0.5 %, while others (e.g. Triton X-100) lyse it completely at 0.1 % (59). 426
Thus, our finding that components such as essential oils do not eliminate infectivity, is equally 427 important as the finding that CPC and LAE in mouthwashes do. CPC-containing mouthwashes were 428 previously reported to reduce infectivity of other enveloped viruses, including HSV (60) and influenza 429 (61), while LAE has shown antiviral activity towards HSV-1, vaccinia virus and bovine parainfluenzae 3 430 (62). Thus, our results may be generally applicable to all enveloped viruses. The finding that LAE is 431 virucidal both above and below cmc, and with or without ethanol, suggests that the virucidal activity 432 of LAE is independent of micellar self-aggregation, and that the transfer of individual surfactant 433 molecules into the viral envelope destabilises the bilayer. The ability of CPC alone, at two 434 concentrations above its cmc (1 mM), to fully inactivate SARS-CoV2 is likely due to micelle-forming 435 surfactants having a very different "packing parameter" than the lipids in the viral bilayer (63). Mixing 436 the surfactant with lipids may increase the local curvature, causing formation of separate micelles, 437 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. The reduction in virucidal effect of CPC caused by benzoate in SCD Max may therefore be due to it 444 reducing the concentration of monomeric CPC. Taken together, our data indicate that whilst product 445 selection is typically made on the basis of individual principal components e.g. CPC, chlorhexidine, or 446 iodine, interactions between ingredients need to be carefully considered. 447
To address the theoretical potential for toxicity of mouthwash with long term use, we compared cell 448 disruption with viral infectivity and found some minor differences ( is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint to address these effects in vivo during the pandemic and both were inconclusive due to small numbers 472 of patients, and the use of qPCR rather than live virus titration to determine virus load (28, 73, 74). 473
Our clinical study was designed in the early part of the pandemic, prior to data becoming available 474
showing that throat virus falls to undetectable levels by 9 days post symptom onset (44). Thus, our 475 study was challenged by recruitment (inability to provide informed consent and provide salivary 476 samples), co-morbidity and the inability to predict patients with saliva containing live virus (<40% of 477 patients). The study was concluded at 6 months with 78 patients randomised; the largest sample to 478 date of any study, with 27 patients having live virus in their saliva. While all mouthwashes were 479 generally beneficial at 1 minute, the CPC mouthwash (Dentyl Dual Action), was the most effective, 480 significantly reducing live viral load over the entire time course, and completely eliminating it for 1h 481 in multiple patients. An important caveat is that mouthwash use will not target virus in the lower 482 respiratory tract; it remains unclear whether virus that transmits to others arises from the upper or 483 lower respiratory tract, although we have shown that infectious virus is found more commonly in the 484 upper than the lower respiratory tract (42). Nevertheless, it remains the case that mouthwashes can 485 destroy enveloped viruses in the oral cavity for sufficient time to enable a dental or oral investigation. 486 Future trials will be required to ensure that this effect is consistent in larger cohorts. However 487 critically, current WHO guidance proposes the use of hydrogen peroxide and PVP-I mouthwashes in 488 dental surgery during the COVID19 pandemic (https://www.who.int/publications/i/item/who-2019-489 nCoV-oral-health-2020.1). However hydrogen peroxide only weakly inactivates SARS-CoV2 (75), and 490 our data shows that surfactant-containing mouthwash is more effective than PVP-I both in vitro and 491 in vivo. Therefore, there may be a need to re-evaluate this advice. 492
In summary, we characterise the lipid membrane of SARS-CoV2, as being primarily comprised of PC, 493 PE and PI, with a high proportion of external aPL, and show that the FA molecular species present may 494 vary depending on host cell. Importantly, an inability to maintain asymmetry in the lipid envelope 495 results in live virus being highly pro-coagulant. We also show that surfactant mouthwash that targets 496 the lipid membrane may be a useful component of infection prevention and control strategies for 497 respiratory enveloped viruses (e.g. influenza, SARS, MERS, in addition to SARS-CoV2), during a 498 pandemic. They have the potential to lessen the risk of transmission from asymptomatic carriers to 499 healthcare professionals performing oropharynx investigations, as well as transmission within the 500 wider population, in a similar manner as to how they are being tested against pathogenic oral 501 bacteria(76-80). Larger population-based studies are now warranted to determine the impact of this 502 biological effect on transmission. Importantly, the anti-viral actions of oral rinses is not dependent on 503 classical antibacterial components, but instead depends on the sensitivity of the lipid envelope to 504 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.22270842 doi: medRxiv preprint surfactants as membrane-disrupting agents, which can be made cheaply and easily in LMICS. The 505 membrane of enveloped viruses is likely to remain susceptible to this approach irrespective of 506 mutations that impact vaccine efficacy. 507
. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint adjusting the pH to 7 using a NaOH solution (pH was determined using a Hanna Instruments pH210 512 microprocessor pH meter with a VWR simple junction universal combined pH/reference electrode) 513 and making up the solution to 50 mL. The required LAE solutions were then prepared by mixing 1 mL 514 of the stock solution and 9 mL of deionised water (3.3 mM), 3 mL of the stock solution and 7 mL of 515 deionised water (9.9 mM) and 1 mL of the stock solution, 6.7 mL of deionised water and 2. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.22270842 doi: medRxiv preprint with DMEM containing 2 % FCS, and 1.2 % Avicel®. After 72 h, the overlay was removed, and the 542 monolayer washed and fixed with 100% methanol. Monolayers were stained with a solution of 25% 543
(v/v) methanol and 0.5 % (w/v) Crystal Violet, then washed with water, and plaques were enumerated. 544
For measurement of toxicity, monolayers were similarly incubated, stained with crystal violet, and 545 scored by eye for live cells. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.22270842 doi: medRxiv preprint criteria for peaks were those at least 5:1 signal-to-noise ratio, and with at least 7 points across the 642 peak. 643
All targeted lipidomics data were statistically analysed using Students T-test, followed by Benjamini 644 Hochberg correction where any lipid category had >20 variables. All statistical data is provided in 645 Source Data file. 646 adducts. Next, all matches with deltaPPM >10 were manually removed. Matches to GL in negative 670 ion data, and matches to FA in positive ion data were removed and reassigned as unknowns, with 671 LMSD identifiers removed. In LipidFinder, to remove baseline noise from blanks, the mean of the blank 672 signals for each ion is subtracted from each lipid sample, where they match by RT and m/z value. Then, 673 every frame that is less than 3 times greater than the solvent mean for every sample is removed. After 674 processing, a manual step was also included where ions that were represented in blank samples at 675 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.22270842 doi: medRxiv preprint >15% the virus sample were judged to be background and removed. Retention time windows based 676 on standards were estimated as follows: lysoPE/PC 10-11 min, PE/PC 6-7 min, Lyso PI 10-12 min, PG 677 2-4 min, PI 8-10 min, LPG 4.5-5.5 min, MAG/TAG/DG 1-3 min, SM 9-11 min, Cer 1.5-3 min. Note that 678 many ions listed in unknowns are likely to be in source fragments, that will match LMSD entries, that 679 were moved to unknown since they are outside the expected RT window. Mass accuracy is broadly 680 considered down to 3 decimal places. Note that this is a largely unvalidated dataset and provided for 681 Table 5 . 698
of conducting assays with live SARS-CoV2 virus, we used a classical assay that doesn't require specialist 700 equipment (81). Here, the activity of both intrinsic and extrinsic pathways of coagulation are 701 measured in re-calcified plasma activated on contact with a negatively-charged provided by a glass 702 test tube, and the ability of live virus to modulate coagulation was tested. Purified SARS-CoV2 virus 703 was resuspended in PBS, then 50 µl added to 50 µl of normal pooled human plasma (Alpha 704
Laboratories, CCN-10), in a glass tube. As a negative control, 50 µl of PBS was added to plasma instead 705 of virus. Samples were incubated at 37 °C for 1 minute, then 50 µl pre-warmed 20 mM CaCl2 added. 706
Samples were incubated at 37 °C and the time until a visible clot formed was measured by visual 707 inspection using a stopwatch. Clot time is defined as any visual evidence for formation of a gel-like 708 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.22270842 doi: medRxiv preprint structure, recognising that these can either be strong and stable, or looser. In control samples, the 709 fibrin clot was formed in around 2 min (120 sec). 710
and actin (cells). Virions were resuspended in NuPAGE LDS sample buffer (Thermo) containing 10 % 712 dithiothreitol (DTT), then samples were loaded onto 14 % Tris-Glycine pre-cast gels (Biorad), and run 713 for 1 h at 20 V. Protein was transferred to nitrocellulose membranes by semi-dry transfer, blocked in 714 blocking buffer (5 % non-fat milk in PBST) for 1 h, then stained with primary antibody for 1 h at room 715 temperature. Membranes were washed, incubated with secondary antibody for 1 h at room 716 temperature, washed, developed with Supersignal West Pico (Thermo), and imaged using a G:Box 717
Chemi XX6 (Syngene). Antibodies were all diluted in blocking buffer, and were rabbit anti-actin (A2066, 718
Sigma-aldrich 1:2,000) and mouse anti-SARS-CoV2 Spike (Clone 1A9, Insight; 1:2,000), as well as anti-719 mouse HRP or anti-rabbit HRP (GE Healthcare; 1:2,000). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.22270842 doi: medRxiv preprint [w/v]) using a balanced randomisation scheme (provided by Dr Damian Farnell, Cardiff University). 742
Baseline saliva was collected into 30 mL Universal containers. The patient then rinsed their mouth for 743 30 seconds with 10 mL of the mouthwash. Saliva samples were then collected after 1, 15, 30 and 60 744 minutes into sterile 30 mL Universal containers. Anonymised samples were transported and stored 745 at -80 o C and transferred to the approved BSL3 facility at Cardiff University where live virus was titrated 746 as above. Results were expressed as log2 fold change from baseline. Clinical and research staff 747 involved in sample collection and laboratory analysis were blinded as to which product was which. 748
Statistical analysis for clinical study: At termination of the study, blinded data was analysed by an 749 independent observer (RGN) who was not involved in the design of the clinical trial or randomisation. 750
All original data on viral load (PFU/mL of saliva), together with the Log2 fold change in from baseline 751 to 60 minutes post-treatment is presented. The viral load from baseline to 60 minutes post-treatment 752 was used to calculate a geometric mean ratio (mean change from baseline to post-treatment). Data 753 was then log transformed. Where virus was not detected, zero values were replaced with 4, just below 754 the lower limit of detection for the assay (5 PFU/ml). Lower and upper confidence limits from the 755 relevant mean and SD on the transformed scale and t and p-values were determined using unpaired t 756 test (Table 5) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint
The copyright holder for this this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.22270842 doi: medRxiv preprint surfactants in widely available oral rinses beyond the level required for EN14476 standard. Panel 997 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Dilution required to prevent toxicity 1.E+00
in vitro analysis and preparation of samples. RGN undertook independent statistical analysis. All 775 authors edited and approved the manuscript. We acknowledge intellectual input from Matthew 776
Maunder for his help in clinical study design
Assembly of the Semliki Forest virus membrane 783 glycoproteins in the membrane of the endoplasmic reticulum in vitro
Quantitative analysis of the lipidomes of the influenza virus envelope and 786 MDCK cell apical membrane
C1q binds phosphatidylserine and likely acts as a multiligand-bridging 788 molecule in apoptotic cell recognition
Identification of a Golgi complex-targeting signal in the 790 cytoplasmic tail of the severe acute respiratory syndrome coronavirus envelope protein
The cytoplasmic tail of the severe acute respiratory 793 syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal 794 that binds COPI and promotes interaction with membrane protein
The C-terminal domain of the MERS coronavirus M protein contains a trans-797 Golgi network localization signal
Sorting of progeny coronavirus from condensed secretory 799 proteins at the exit from the trans-Golgi network of AtT20 cells
Site of addition of N-acetyl-galactosamine to the E1 802 glycoprotein of mouse hepatitis virus-A59
Lipids of the Golgi membrane
Viral apoptotic mimicry
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, 806 infectious disease, and cancer
Phosphatidylserine vesicles enable efficient en bloc transmission of 808 enteroviruses
A pathogenic picornavirus acquires an envelope by hijacking cellular 810 membranes
Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter 812 host cells
Role of the 814 phosphatidylserine receptor TIM-1 in enveloped-virus entry
Role of phosphatidylserine receptors in enveloped virus infection
Mechanically ventilated patients shed high titre live SARS-CoV2 for extended 874 periods from both the upper and lower respiratory tract. medRxiv
Analysis of the interactions of a cationic surfactant (lauric 877 arginate) with an anionic biopolymer (pectin): isothermal titration calorimetry, light 878 scattering, and microelectrophoresis
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral 880 shedding, and infectiousness: a systematic review and meta-analysis
Phospholipid synthesis and transport in mammalian cells
Functional rafts in cell membranes
Cellular cholesterol trafficking and compartmentalization
Effect of cholesterol on the structure of a phospholipid bilayer
Dynamics of the hydrocarbon layer in liposomes of lecithin and 889 sphingomyelin containing dicetylphosphate
Does Cholesterol Play a Role in the Bacterial 891 Selectivity of Antimicrobial Peptides?
beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic 893 Secretory Pathway
Tracheal epithelial cell fatty 895 acid composition modulates prostaglandin E2 and cAMP production
Phospholipid fatty acid composition of pulmonary 898 airway epithelial cells: potential substrates for oxygenation
Influenza and cardiovascular 901 disease: is there a causal relationship?
Seasonal Influenza Infections and Cardiovascular Disease Mortality
Association between influenza vaccination and cardiovascular outcomes in 905 high-risk patients: a meta-analysis
Comparative study on the antiviral activity of selected 907 monoterpenes derived from essential oils
Efficacy of Listerine Antiseptic in reducing viral contamination of saliva
Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media
Nucleic Acid Extraction Reagents, Detergents, and Fixatives
Development of novel microemulsion-based topical 913 formulations of acyclovir for the treatment of cutaneous herpetic infections
Cetylpyridinium Chloride (CPC) Exhibits Potent, Rapid Activity Against 916 Influenza Viruses in vitro and in vivo
Theory of Self-Assembly of Hydrocarbon 919
Amphiphiles into Micelles and Bilayers
Semiequilibrium 922 dialysis study of the solubilization of benzoate anion by aqueous hexadecylpyridinium 923 chloride
Aggregation and adsorption behavior of cetylpyridinium 925 chloride in aqueous sodium salicylate and sodium benzoate solutions
Aggregation and reactivity in aqueous solutions of cationic surfactants and 928 aromatic anions across concentration scales
Mouthwash use in general population: results from adult dental health 931 survey in grampian, Scotland
Cytotoxicity and Antimicrobial Activity of 933 Oral Rinses In Vitro
Over-the-counter 935 mouthwash use and risk of pre-diabetes/diabetes
Efficacy of two mouthwashes with cetylpyridinium chloride: a controlled 937 randomized clinical trial
Association between periodontitis and severity of COVID-19 infection: A case-939 control study
Comorbidity of periodontal disease: two sides of the same coin? An 941 introduction for the clinician
Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva
Chlorhexidine mouthwash reduces the salivary viral load of SARS-CoV-2: A 945 randomized clinical trial
Effective in-vitro inactivation of SARS-CoV-2 by commercially 947 available mouthwashes. bioRxiv
Antibacterial mouthwash to prevent sexually transmitted infections in men 949 who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-950 controlled, crossover trial
Antiseptic mouthwash against pharyngeal Neisseria 952 gonorrhoeae: a randomised controlled trial and an in vitro study
Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a 955 randomised, double-blind, parallel-group, multicentre trial
New thinking on gonorrhoea control in MSM: are 958 antiseptic mouthwashes the answer? Current opinion in infectious diseases
Antiseptic mouthwashes against sexually transmitted 960 infections
Practical-Haemostasis.com, A Practical Guide to Haemostasis
Inhibition was calculated relative to virus incubated with media alone (n = 1 (virus toxicity) or 2 (cell 1022 toxicity, mean), representative of 3 independent experiments)
Haemost 88, 186-193 (2002 membrane was stained with mouse anti-SARS-CoV2 Spike antibody and exposed for 30 sec. Bands 1050 corresponding to S1/S2 (~200kDa), and cleaved S1 (~80kDa) domains are observed. Panel B. 1051Immunostaining of actin. The gel was stripped and reprobed with rabbit anti-actin antibody, then 1052 exposed for 3 min. Note that in addition to actin (~40kDa), incomplete stripping of anti-Spike antibody 1053 was also observed. 1054 • 51 patients were excluded from Analysis based on absence of live SARS CoV2 in saliva at baseline